Alan W. Dunton serves as Executive at Adams Respiratory Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Alan W. Dunton has executed 111 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 13, 2008 involved receiving (via award) 100,000 shares valued at $0.
Alan W. Dunton currently holds 70,703 shares of Adams Respiratory Therapeutics, Inc. (ARXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan W. Dunton has been a net seller of ARXT stock. They have purchased $174.3K and sold $964.0K worth of shares.
Alan W. Dunton's most recent insider trade was on Feb 13, 2008, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $60.00 |
| Discretionary |
| Jan 2, 2008 | ARXT | $0 | Award | 210 | $N/A | Discretionary |
| Dec 18, 2007 | PANC | $0 | Award | 100,000 | $N/A | Discretionary |
| Dec 14, 2007 | PANC | $25.0K | Purchase | 30,865 | $0.81 | Discretionary |
| Oct 1, 2007 | ARXT | $0 | Award | 323 | $N/A | Discretionary |
| Aug 3, 2007 | PANC | $25.1K | Purchase | 10,000 | $2.51 | Discretionary |
| Jul 2, 2007 | ARXT | $0 | Award | 316 | $N/A | Discretionary |
| Apr 2, 2007 | ARXT | $0 | Award | 374 | $N/A | Discretionary |
| Jan 3, 2007 | ARXT | $0 | Award | 300 | $N/A | Discretionary |
| Nov 8, 2006 | ARXT | $0 | Award | 100 | $N/A | Discretionary |